Search - tctmd.com

Displaying 61 - 69 of 69

Sort: Relevancy | Date

News Opinion Editor's Corner ESC 2017

ESC 2017: In Tragedy’s Wake, Cardiology’s Biggest Congress Forges On

Shelley Wood

August 18, 2017

News Daily News

How SGLT2 Inhibitors Help the Heart: Biomarker Study Offers Clues

Leah Lawrence

August 01, 2017

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for February 2017

Shelley Wood

March 01, 2017

News Daily News

Stroke Not the Only Concern in Patients With A-fib

Todd Neale

September 07, 2016

News Opinion Fellow Talk

Hemodynamics Galore: What I Learned at the C3 Summit

Tiffany Patterson, MBBS

July 27, 2016

News Daily News

Year in Review: Physicians Select the Most Important News of 2015, in Interventional Cardiology and Beyond

December 23, 2015

News Industry News

ISIS Pharmaceuticals Reports Data from ISIS-TTR Rx in patients with Transthyretin Amyloid-Related Cardiomyopathy

July 27, 2015

News Industry News

Resverlogix Officially Attains Phase 3 Status with a European Regulatory Authority

June 22, 2015

News Industry News

Juventas Therapeutics Presents New 12-Month Data Demonstrating Single Administration of JVS-100 Improves Cardiac and Clinical Status in Patients with Severe Ischemic Heart Failure One Year After Treat

May 26, 2015

Advertisement

ESC 2017: In Tragedy’s Wake, Cardiology’s Biggest Congress Forges On

How SGLT2 Inhibitors Help the Heart: Biomarker Study Offers Clues

TCTMD’s Top 10 Most Popular Stories for February 2017

Stroke Not the Only Concern in Patients With A-fib

Hemodynamics Galore: What I Learned at the C3 Summit

Year in Review: Physicians Select the Most Important News of 2015, in Interventional Cardiology and Beyond

ISIS Pharmaceuticals Reports Data from ISIS-TTR Rx in patients with Transthyretin Amyloid-Related Cardiomyopathy

Resverlogix Officially Attains Phase 3 Status with a European Regulatory Authority

Juventas Therapeutics Presents New 12-Month Data Demonstrating Single Administration of JVS-100 Improves Cardiac and Clinical Status in Patients with Severe Ischemic Heart Failure One Year After Treat

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content